Globoid cell leukodystrophy (GLD), or Krabbe disease, is a rare and often fatal demyelinating disease caused by mutations in the galactocerebrosidase (galc) gene that result in accumulation of galactosylsphingosine (psychosine). We recently reported that the extracellular matrix (ECM) protease, matrix metalloproteinase-3, is elevated in GLD and that it regulates psychosine-induced microglial activation. Here, we examined central nervous system ECM component expression in human GLD patients and in the twitcher mouse model of GLD using immunohistochemistry. The influence of ECM proteins on primary murine microglial responses to psychosine was evaluated using ECM proteins as substrates and analyzed by quantitative real-time polymerase chain reaction, immunocytochemistry, and ELISA. Functional analysis of microglial cytotoxicity was performed on oligodendrocytes in coculture, and cell death was measured by lactose dehydrogenase assay. Tenascin-C (TnC) was expressed at higher levels in human GLD and in twitcher mice versus controls. Microglial responses to psychosine were enhanced by TnC, as determined by an increase in globoid-like cell formation, matrix metalloproteinase-3 mRNA expression, and higher toxicity toward oligodendrocytes in culture. These findings were consistent with a shift toward the M1 microglial phenotype in TnC-grown microglia. Thus, elevated TnC expression in GLD modified microglial responses to psychosine. These data offer a novel perspective and enhance understanding of the microglial contribution to GLD pathogenesis.
INTRODUCTION
Globoid cell leukodystrophy (GLD), also known as Krabbe disease, is a fatal demyelinating disease with an incidence of 1 in 100,000 in the United States (1, 2) . The cause of GLD is attributed to genetic loss-of-function mutations in the lysosomal enzyme galactosylceramidase (GALC) gene (3) . The natural function of GALC is to hydrolyze galactolipids, including the toxic lipid galactosylsphingosine psychosine. Hydrolysis of psychosine is thought to prevent cellular damage (4) . Thus, its mutation in GLD results in supraphysiologic accumulation of psychosine (5) . It is widely accepted that abnormal accumulation of psychosine drives GLD pathology through its pathophysiologic effects on multiple cell types (5) , but the exact mechanism of action of psychosine and the sequence of cellular involvement culminating in GLD pathology remain unclear.
The neuropathologic hallmarks of GLD include severe central nervous system (CNS) demyelination, extensive astrogliosis, and the presence of large multinucleated phagocytes called globoid cells. It has been suggested that formation of globoid cells in GLD was a secondary response to profound CNS demyelination; however, we recently determined that globoid cells are likely a primary response of microglia to psychosine (6) . These data support an emerging hypothesis that psychosine induces widespread pathologic changes in many cell types. Moreover, the response of microglia to psychosine provides a new model to study the unique formation and specific function(s) of globoid cells found within the CNS in GLD.
The extracellular matrix (ECM) is an intricate macromolecular network that occupies the extracellular space in tissues that provides a structural framework and homeostatic signaling environment for cells. Differential production of ECM components has been reported in many CNS diseases, including Alzheimer disease (7) , stroke (8) , human immunodeficiency virus encephalitis (9) , and multiple sclerosis (MS) (10) . One widely studied implication of altered ECM composition includes dysregulation of cellular growth, differentiation, and cell fate (11Y14). For example, in acutely demyelinated lesions in MS, tenascin-C (TnC) levels have been reported to be decreased relative to unlesioned or healthy tissues (15) ; whereas in chronically demyelinated lesions, elevated production of TnC from astrocytes has been observed (15, 16) . These changes in TnC levels associated with myelin lesions have led to the suggestion that TnC may negatively influence the remyelinating potential of oligodendrocyte progenitor cells in and around myelin lesions (15, 16) . Increased production of fibronectin in MS has also been reported to pathologically alter glial responses. Recently, Stoffels et al (17) reported that astrocyte-derived fibronectin can prevent oligodendrocyte differentiation, therein contributing to the chronicity of demyelinated lesions in MS. In addition, excessive fibrillar collagen production around actively demyelinating lesions in MS has been suggested to impair the expression of potentially beneficial chemokines from infiltrating monocytes (18) . Thus, changes in ECM composition are closely associated with the pathology of demyelination and may represent important mediators of disease-related cellular responses in CNS diseases.
The distribution and expression of ECM constituents are tightly regulated not only at the transcriptional and translational level but also through extracellular proteolysis by matrix metalloproteinases (MMPs). Most ECM components are enzymatic substrates of MMPs, and degradation of ECM by MMPs can have profound effects on cellular signaling (19) . We previously determined that MMP-3 (stromelysin-1) is highly expressed in human and mouse GLD brains (6) . We also determined that MMP-3 mediated psychosine-induced multinucleation of microglia with increased phagocytic activity (6). Because we have determined that psychosine induced MMP-3Ydependent formation of multinucleated microglia, or globoid cells, this finding led us to hypothesize that changes in ECM may contribute to the pathophysiology of microglia in GLD. Moreover, because the precise role of globoid cells in GLD is currently unclear, we also sought to determine whether globoid cells had a direct effect on the survival of oligodendrocytes.
In this study, we determined that expression of TnC was specifically elevated in GLD and that it fostered the pathogenic transformation of microglia in response to psychosine by promoting their cytotoxic potential toward oligodendrocytes.
MATERIALS AND METHODS

Animals for Primary Cultures
All procedures involving animals were conducted with approval from the Institutional Animal Care and Use Committee at the University of Connecticut Health Center and in accordance with guidelines set forth by the National Research Council of the National Academies Guide for the Care and Use of Laboratory Animals.
Mixed Glial Cultures
Primary mixed glial cultures were established from postnatal day (P)0-3 pups of C57/BL6 wild-type mice, as previously described (6, 20) . Briefly, cortices were manually dissected in cold HBSS, followed by mechanical and enzymatic dissociation using a papain-based neural dissociation kit (Miltenyi Biotec, Auburn, CA), according to the manufacturer's protocol. Dissociated cells were plated in DMEM (Gibco, Carlsbad, CA) with 10% fetal bovine serum ([FBS] Atlanta Biologicals, Lawrenceville, GA), penicillin (100 U/mL; Sigma Aldrich, St Louis, MO) and streptomycin (100 mg/mL; Sigma Aldrich) in a T175 culture flask (Grenier Bio-One, Frickenhausen, Germany). After 16 hours, the culture medium was replaced with fresh medium to remove nonadherent cells. Adhered cells were incubated in the flask at 37-C for 2 to 3 weeks until an astrocytic monolayer was established.
Primary Microglial Cultures
Pure microglial cultures were established by detaching microglia from mixed glial cultures, as previously described (6, 21) . Briefly, established mixed glial cultures with 100% confluency were shaken by orbital shaker at 110 rpm at 37-C for 4 hours to detach microglia from the astrocytic monolayer. Supernatants containing detached microglia were spun at 300 Â g for 10 minutes, followed by resuspension of the microglia in astrocyte-conditioned media, and then plated onto coverglass coated with either laminin (Lm) (10 Kg/mL; Sigma) or TnC (1,10, or 100 Kg/mL; EMD Millipore, Billerica, MA) or into 6-well UltraLow adherence culture plates (Corning, Tewksbury, MA). Cells were acclimated for 2 to 3 days before experiments. Chemical inhibitors used were GM6001 (12.5 Kmol/L; Calbiochem, Billerica, MA) and NNGH (0.1 Kmol/L; Enzo Life Sciences, Farmingdale, NY), psychosine (10 Kmol/L; Sigma), dimethylsulfoxide (0.13% DMSO; Sigma Aldrich).
Primary Oligodendrocyte Cultures
Pure oligodendrocyte cultures were established from postnatal (P)0-3 rat pups, as described previously (22) , with modifications. Briefly, brains from rat pups were dissected out, and meninges were removed. After removal of the cerebellum, the brain tissue was mechanically dissociated by mincing with scissors and passing through fire-polished Pasteur pipettes. The single-cell suspension was then plated in a T75 flask in maintenance medium composed of DMEM/F12 (Gibco), 10% FBS (Atlanta Biologicals), penicillin (100 U/mL; Sigma Aldrich), and streptomycin (100 mg/mL; Sigma Aldrich). Cells were incubated at 37-C for 3 weeks or until a monolayer was formed. Cultures were shaken for 30 minutes (37-C at 55 rpm) to remove microglia from the monolayer. Oligodendrocyte progenitor cells were removed by shaking in an orbital shaker at 225 rpm at 37-C for 16 hours. Medium containing detached cells was collected and centrifuged at 300 Â g for 10 minutes. Cells were resuspended in maintenance media and plated 3 to 4 hours at 37-C to eliminate microglia by differential adhesion. Nonadhering cells were collected and plated on poly-ornithine (0.1% Sigma Aldrich)Ycoated coverglass, incubated for 1 to 2 hours at 37-C, and the medium was replaced with an oligodendrocyte differentiation medium, composed of Neurobasal media (Gibco), lglutamine (1Â; Life Technologies, Grand Island, NY), B-27 supplement (1Â; Life Technologies), and triiodothyronine (T3, 10 ng/mL; Sigma Aldrich).
Cocultures of Microglia and Oligodendrocytes
Primary microglial cultures in 6-well UltraLow adherence culture plates and oligodendrocyte cultures on polyornithine coated coverslips were established as described above. To induce globoid cells in microglia, psychosine, psychosine + TnC, or vehicle treatments were applied for 7 consecutive days; then, treated microglia were collected by gentle pipetting to detach loosely adhered cells at the bottom of wells. Collected cells were spun (300 Â g for 10 minutes), and cells were carefully resuspended in oligodendrocyte differentiation media (see above). The microglia in single cell suspension were counted by hemacytometer and seeded at 0.5Y1 Â 10 5 cells/mL onto oligodendrocyte cultures, which resulted in approximately 1:1Y2 microglia/oligodendrocyte ratio. Co-cultures were incubated for 3 d and media were collected for cytotoxicity assay and the cells were fixed for immunocytochemistry (ICC).
Primary Neuronal Cultures
Primary cortical or hippocampal neuronal cultures were established from rat pups at P1 (23) . Briefly, brains from rat neonates were dissected out, and meninges were stripped off. Cortices and hippocampi were isolated in HBSS, followed by incubation for 15 minutes at 37-C in trypsin (0.25%). Tissues settled at the bottom of conical tubes were washed with HBSS 3 times; this was followed by tituration with a fire-polished Pasteur pipette 10 times in plating media (Neurobasal media with 10% FBS). Single-cell suspensions were passed through a 70-Km filter and then plated on poly-L-lysineYcoated plates. 
Human Brain Tissues
Brain specimens from GLD and age-matched control patients (1Y2 years old) were obtained from the National Institute of Child Health and Human Development Brain and Tissue Bank for Developmental Disorders (Baltimore, MD). Brain tissues were paraffin embedded, cut into 15-Km-thick sections, and then processed for immunohistochemistry (IHC).
Mouse Brain Tissues
Twitcher mice were bred and housed at the SanfordBurnham Institute (La Jolla, CA), where the brain specimens from twitcher mice and age-matched littermate control mice were collected. Mice were deeply anesthetized in accordance with Institutional Animal Care and Use CommitteeYapproved protocols and were transcardially perfused with phosphate buffer saline (PBS) followed by 4% paraformaldehyde. Brain tissues were collected at the age of P0, 10, 20, 31, 40, as previously described (24) .
Immunohistochemistry
Collected brain and spinal cord tissues were paraffin embedded, and 15-Km sagittal sections were made, as previously described (25, 26) . Tissue sections were subjected to antigen retrieval using 95-C citric acid buffer (0.01 mol/L, pH 6.0), followed by blocking nonspecific binding site by 5% normal goat serum (Life Technologies) in PBS-Tween for 1 hour at room temperature. Sections were then incubated with primary antibodies against TnC (N-19; Santa Cruz Biotechnology, Dallas, TX), Ln (>-2 [6D580], Santa Cruz), vitronectin (10/65/75 [H-202], Santa Cruz Biotechnology), fibronectin (C-20; Santa Cruz Biotechnology), Iba-1 (019-19741; Wako, Richmond, VA), and/or CD16/32 (553142; BD PharMingen), followed by PBS wash and 1-hour incubation with Alexa 594Y or 488Yconjugated secondary antibodies (Life Technologies) against appropriate species from which primary antibodies were raised. To identify nuclei, tissues were counterstained with 4 ¶,6-diamidino-2-phenylindole ([DAPI] Life Technologies) and then coverslipped using Fluoromount-G (Southern Biotech, Birmingham, AL). Immunoreactivity was visualized and then analyzed using a computer-assisted image analysis system and software (Eclipse, Empix Imaging) on an Olympus IX71 microscope. For each experimental treatment, 2 to 4 different specimens were analyzed and experiments were also repeated in triplicate. Data presented are from a representative experiment unless otherwise indicated.
Thioflavin-S Staining
After labeling of TnC using primary and secondary antibodies in IHC (see IHC section), tissues were then incubated with 0.1% thioflavin-S (Sigma Aldrich) in PBS:EtOH (1:1, vol/vol) for 5 minutes at room temperature. Tissues were then washed with 80% EtOH several times, rehydrated with PBS, and then analyzed.
Quantitative Real-time Polymerase Chain Reaction
Total RNA was isolated from cultured cells as described previously (6) and converted into complementary DNA (cDNA) via reverse transcription (iScript cDNA synthesis kit; BioRad, Hercules, MA), according to the manufacturer's protocol. Synthesized cDNA samples were amplified for quantitative real-time polymerase chain reaction (qRT-PCR) using primer pairs specific to mmp-3 and tenascin-c mRNA (Integrated DNA Technologies, Coralville, IA), as described previously (27) , and SsoFast EvaGreen Supermix (BioRad) according to the manufacturer's protocol. Target cDNA was amplified and analyzed by a Mastercycler ep realplex (Eppendorf, Hauppauge, NY). Primers for GAPDH were used to assess the general expression level of the housekeeping gene among samples. The relative expression of target RNA was calculated using the comparative cycle threshold analysis ($$C T ), as previously described (6) .
Immunocytochemistry
Cells plated and grown on Lm-coated or polyornithineYcoated glass coverslips were fixed using 4% paraformaldehyde and processed for ICC using antibodies against Iba-1 (Wako), CD11b (eBioscience, San Diego, CA), Olig2 (EMD Millipore), myelin basic protein (aa82-87, EMD Millipore), CD206 (C-20, Santa Cruz Biotechnology), and major histocompatibility complex II ([MHCII] Y-Ae; Santa Cruz Biotechnology), following blocking by 5% normal goat serum (Life Technologies), as previously described (26) . Immunoreactivity was visualized using fluorescently conjugated secondary antisera against the species of the primary antibodies (Alexa Fluor 488 or 594; Life Technologies). Positive immunostaining were viewed and analyzed using computerassisted image analysis software on an Olympus IX71 microscope. 4 ¶,6-Diamidino-2-phenylindole staining was used to label nuclei to determine cellular densities per field and multinucleated cell analyses, as previously described (6) . Four to 6 visual fields were randomly chosen per coverslip, and the number of cells with single and/or multiple immunoreactivities were manually counted using ImageJ software (National Institutes of Health) and also normalized to total DAPIpositive nuclei per field.
Lactose Dehydrogenase Assay
Media from cell cultures were collected at the end of the treatment time course. The level of lactose dehydrogenase in collected media was measured using a commercial lactose 
Enzyme-Linked Immunosorbent Assay
Media were collected from cell cultures at the end of the experiments. The level of tumor necrosis factor (TNF) released into media was analyzed using a commercially available TNF ELISA DuoSet kit per manufacturer's instructions (R&D Systems, Minneapolis, MN).
Statistical Analysis
Data are presented as mean T SE. Statistical significance was tested by one-way analysis of variance (ANOVA) with Tukey post hoc analysis or two-way ANOVA with Bonferroni post hoc test using Prism software (GraphPad, San Diego, CA). For all comparisons, p G 0.05 was considered statistically significant.
RESULTS
TnC Expression Is Elevated in the GLD Brain
The emerging recognition of the significance of ECM molecules on glial cell functions led us to consider whether differential expression of ECM molecules occurred in GLD. To explore this, we performed IHC for 4 prominent ECM molecules: Lm, fibronectin, vitronectin, and TnC on brain tissue sections from human brain from GLD cases and agematched control subjects. Examination of the expression of the ECM components Lm, fibronectin, and vitronectin revealed no significant differences between GLD and control brains in terms of their pattern of expression or intensity of immunostaining (Fig. 1A) . However, there were TnC-positive deposits in the brains of GLD patients but not in age-matched control subjects (Fig. 1A) . Next, we examined whether TnC was a generalized feature of GLD brain pathology across species. Tenascin-C immunoreactivity was analyzed in brain tissues from twitcher mice, an authentic mouse model of GLD (28) . Similar to the human GLD cases and control brains, there were no significant differences in staining for Lm, fibronectin, or vitronectin between the 2 genotypes, but TnCpositive deposits were more frequently observed in twitcher brains than in age-matched controls (Fig. 1B) . Interestingly, the high TnC immunoreactivity in twitcher mice was frequently observed in plaque-like patterns, which resembled the staining observed in human GLD. This pattern also exhibited similarities to A-amyloid deposits observed in Alzheimer disease and, in fact, TnC-positive plaques were frequently colocalized with thioflavin-S, a marker of amyloid fibrils ( [29] Fig. 1C) . Together, these data indicate that the intensity and pattern of TnC immunoreactivity are altered in the CNS of GLD-affected humans and mice.
TnC Enhances Glial Responses to Psychosine In Vitro
Extracellular matrix proteins have the potential to potently modulate glial functions. Based on the high expression of TnC in GLD brains (and previously reported effects of TnC on glia [30Y32]), we next examined whether TnC influenced microglial responses to psychosine. We previously reported that psychosine induced globoid cell formation in glial cultures (6) . Using this in vitro model system, we prepared primary mixed glial cultures that were grown on either TnC or Lm (Fig. 2) . Cultures were then exposed to psychosine (10 Kmol/L) for 7 consecutive days. Immunocytochemical analyses determined that globoid cells formed in response to psychosine when grown on either ECM substrate (Fig. 2AYD) . However, in glial cultures grown on TnC, there were significantly more psychosineinduced globoid cells formed than in glial cultures grown on Lm (Fig. 2E) . These data suggest that TnC enhanced globoid cell formation in response to psychosine in vitro.
Because we had previously determined that induction of globoid cells by psychosine required MMP-3 (6), we examined MMP-3 expression. To determine whether TnC modified psychosine-induced MMP-3 expression by glia, we (Fig. 3A) . To determine whether the concentration of TnC was a factor determining the magnitude of MMP-3 expression, we plated mixed glial cultures onto varying concentrations (1, 10, or 100 Kg) of TnC substrate and then treated these cultures with psychosine for 72 hours, the time point of maximal MMP-3 expression on 1 Kg TnC (Fig. 3A) . On 100 Kg TnC, cultures exhibited highly variable adherence and survival, which precluded these cultures from further analysis. However, analysis of MMP-3 mRNA expression in the adherent cultures treated with psychosine grown on either 1 or 10 Kg concentrations of TnC revealed a strong correlation between the concentration of TnC and MMP-3 (Fig. 3B) . These data suggest that microglia grown on TnC exhibit a more robust transcriptional response to psychosine than on Lm, and that MMP-3 expression in response to psychosine is strongly influenced by TnC in a concentrationdependent manner.
We next tested whether the enhanced formation of globoid cells grown on TnC was also mediated by MMP-3. TenascinCYgrown glial cultures were challenged with psychosine in combination with a pan-MMP inhibitor (GM6001), MMP-3-specific inhibitor (NNGH), or vehicle (DMSO) for 7 consecutive days. Immunocytochemical analysis determined that treatment with either GM6001 or NNGH significantly attenuated the psychosine-induced globoid cell formation of TnC-grown microglial cultures (Fig. 3C ). These data confirmed that psychosine-induced globoid cell formation was mediated by MMP-3 but also revealed that this process was enhanced by recapitulating the ECM environment of the GLD brain, that is, TnC.
TnC Modifies Microglial Phenotype in Response to Psychosine
Globoid cells originate from microglia (6). Our previous study had determined that psychosine induced phagocytic activity of microglia, but we had not fully characterized the phenotype of these cells. Because microglia can have detrimental or beneficial effects, based on their phenotypes, known as M1 and M2, respectively (33, 34), we next determined the phenotype of both mononuclear and multinucleated microglia after treatment with psychosine or psychosine and TnC. Microglial phenotypes were determined by ICC using the expression of MHCII or CD206 on Iba-1Ypositive microglia as indicators of the classic M1 and M2 phenotypes, respectively. We analyzed the phenotype of the multinucleated microglia (globoid cells) induced by psychosine when grown in either the presence or absence of TnC (Fig. 4A, B) . The number of MHCII-positive globoid cells in psychosinetreated microglia grown on TnC was slightly higher than those in microglia grown without TnC, albeit without a statistically significant difference (Fig. 4D) . Conversely, the number of CD206-positive globoid cells from psychosinetreated microglia was significantly greater than psychosinetreated microglia exposed to TnC (Fig. 4C) . These data provide support for a distinct M1-microglial phenotype of microglia in response to psychosine when grown on TnC, 
TnC Determines the Cytotoxicity of Globoid Cells for Oligodendrocytes
We previously reported that when microglia were treated with psychosine in vitro, they transform into large highly phagocytic multinucleated cells (6) . Also, globoid cells in the brains of human GLD patients, twitcher mice, and other animal models of GALC deficiency have often been found close to myelin lesion sites and to contain tubular inclusions and myelin debris (35) . Thus, we hypothesized that globoid cells phagocytize myelin and possibly accelerate disease process(es) of GLD by promoting demyelination and oligodendrocyte death. To test this, isolated microglia were grown on low-adherence plates with or without TnC and then treated with psychosine (10 Kmol/L) or vehicle. Microglia were then collected and cocultured with primary oligodendrocyte cultures. The impact of microglia on oligodendrocytes in culture was then assessed by ICC for Olig2, an oligodendrocyte marker (Fig. 5A) , and the amount of cell death in cultures was evaluated using a lactose dehydrogenase assay. Psychosine-treated microglia exhibited less cytotoxicity to oligodendrocytes than observed in control-treated microglia (Fig. 5B, C) . In contrast,psychosine-treated microglia grown on TnC evoked a 2.9-fold increase over psychosine-treated microglia without TnC (Fig. 5D ), in terms of cytotoxicity to oligodendrocytes, or when compared with control-treated microglia (Fig. 5E) .
We next measured TNF production in these cocultures by ELISA to determine whether psychosine modulated microglial production of TNF. Microglia treated with psychosine exhibited a measurable reduction in TNF production (Fig. 5B) . Overall, psychosine-treated microglia had significantly less cytotoxicity on oligodendrocytes than nontreated microglia in coculture, whereas psychosine-treated microglia grown on TnC displayed significantly greater toxicity to cocultured oligodendrocytes and higher TNF. These data suggest that psychosine can promote a potentially pathogenic phenotype of microglia in the presence of TnC. These data also suggest that psychosine reduced the intrinsic toxicity of microglia to oligodendrocytes, but that the local production of TnC in GLD overcomes and promotes this cytotoxicity, potentially through modulating TNF production from microglia.
Detection of M1 Polarized Microglia and Globoid Cells in Human GLD
Recent studies have determined that the polarization of microglia and macrophages can dramatically impact the potential for recovery and repair in models of white matter injury (33, 36) . Our in vitro data indicated that the presence of TnC in GLD may polarize the phenotype of microglia toward a classically activated oligotoxic M1 phenotype. To evaluate the phenotype of microglia in GLD, we examined whether Iba-1Ypositive microglia also coexpressed CD16/32, an M1 activation marker, in human GLD brain tissue (Fig. 6 ). Microglia were abundant in the brainstem and exhibited highly activated states, as evident in their morphology, with short thickened processes or amoeboid forms. Immunohistochemical detection of CD16/32 also revealed colocalization with clusters of Iba-1Ypositive microglia (Fig. 6A) . Expression of the CD16/32 M1 phenotype marker was most pronounced on multinucleated globoid cells within regions of abundant Iba-1Ypositive cells in presumptive degenerating white matter tracts (Fig. 6B) . Together, these data indicate the presence of M1 microglia in GLD and suggest a potential role for microglial polarization in GLD pathology and white matter injury.
DISCUSSION
In this study, we determined that TnC production was enhanced in twitcher mouse and human GLD brain samples. Microglial responses to psychosine were enhanced by TnC, as measured by both increased MMP-3 expression and globoid cell formation in vitro. These data suggest that localized accumulation of TnC may have the potential to modify microglial responses to psychosine. The impact of this TnC modulation was revealed by our investigation on the cytotoxicity FIGURE 5. Globoid cells grown on tenascin-C (TnC) are toxic to oligodendrocytes. Isolated microglia treated with psychosine (+Psy), grown on TnC and treated with psychosine (+Psy + TnC), or vehicle for 7 days were then cocultured with oligodendrocytes for 4 subsequent days. Oligodendrocyte cultures were about 50% myelin basic protein positive at the time of coculture. Representative photomicrographs of immunocytochemistry for Olig2 (red) and CD11b (green) counterstained with DAPI (nuclei; blue) in cultures of oligodendrocytes (A), oligodendrocytes cocultured with microglia (B), oligodendrocytes cultured with psychosinetreated microglia that were grown on a laminin substrate (C), or oligodendrocytes cultured with psychosine-treated microglia that were grown on a TnC substrate (D). Scale bar = 100 Km. (E) Analysis of cell death under each condition was measured by lactose dehydrogenase assay. Cytotoxicity is expressed as the percentage of full kill control (0.1% sterile Triton X-100). Psychosine-induced globoid cells without TnC (black bar) had minimal toxicity in coculture to oligodendrocytes versus untreated microglia (gray bar), whereas TnC-grown psychosine-treated microglia exhibited significant toxicity (striped bar). (F) Level of tumor necrosis factor (TNF>) released from isolated microglia treated with psychosine, TnC-grown microglia treated with psychosine, or vehicle control (7 days) was measured by ELISA. Note that psychosine-treated microglia (black bar) exhibited the least amount of TNF> release versus untreated or TnC-exposed psychosine-treated microglia (gray, striped bar, respectively). One-way ANOVA, p G 0.001; where * p G 0.05; ** p G 0.01; *** p G 0.001. n = 3 per condition.
of globoid cells toward oligodendrocytes. We determined that globoid cells plated on TnC evoked a higher level of cell death in coculture with oligodendrocytes than globoid cells without TnC. Strikingly, naive microglia also showed significantly greater toxicity to oligodendrocytes than psychosine-treated microglia, which reduced the native toxicity of microglia toward oligodendrocytes. Together, these data suggest that, by recapitulating the ECM microenvironment of GLD, we influenced the cellular phenotype of microglia; this may be an important consideration for modeling disease-like responses in cell culture systems. Moreover, the findings support a more prominent and primary function for microglia and globoid cells as putative direct inducers of myelin pathology in GLD.
Alterations of the ECM have gained increasing interest for their relationship and contribution to myelin pathologies. In this study, we determined that TnC was differentially expressed in GLD. Tenascin-C has many known functions in modulating cellular growth and maturation and also the repulsion of cells via local detachment (37) . We determined that microglia grown on TnC elicited a more robust increase in psychosine-induced MMP-3 expression and enhanced globoid-like cell formation. In previous studies on traumatic brain injury and Alzheimer disease, TnC expression has been closely associated with both astrocytes and microglia (30, 32, 38Y40) . The cellular source of TnC remains an open but important question related to GLD pathology. We speculate that if TnC is not transcriptionally regulated by psychosine, then inflammatory factors, such as TNF and/or interleukin-1 (41, 42) , which are greatly upregulated in GLD brains (43) , may modify the ECM in GLD.
We previously reported that psychosine transforms microglia into a multinucleated phenotype with high phagocytic activity (6) . Here, we explored the potential effect of psychosine-induced globoid cells on oligodendrocytes. Interestingly, psychosine-induced globoid cells exhibited a predominant M2 phenotype, with reduced cytotoxicity to oligodendrocytes when compared with untreated microglia. This suggests that globoid cells may be either benign or beneficial in GLD. The effect of TnC on the microglial response to psychosine-induced globoid cells (and this affects the oligodendrocyte coculture system) was dramatic, with a shift toward an oligotoxic M1 phenotype. Our data also indicated that psychosine modulation of microglial function correlated with and may be mediated by TNF. We hypothesize that TnC accumulation in GLD contributes to white matter pathology via altering the microglia response to psychosine-induced demyelination. This provides a new prospective on the role of globoid cells and the extracellular environment in GLD. The mechanism by which the combination of TnC and psychosine promotes microglial toxicity to oligodendrocytes is presently unclear. Previous studies in other disease models have shown that altered ECM, associated with neuropathology, can modify the production of growth factors such as ciliary neurotrophic factor, fibroblast growth factor, epidermal growth factor, and tumor growth factor (30, 32, 38Y40) . Future studies would be warranted to understand how TnC-modified microglia, in association with aberrant MMP-3 expression, contribute to the inflammatory environment of the CNS in GLD.
One possible mechanism by which TnC alters the phenotype and response of microglia to psychosine is through differential expression of their ECM receptors. Several integrins, including >v, A1, and A2 families (44) , are thought to be TnC receptors. Tenascin-C binds to >vA3, >vA6, >9A1, and >8A1; these are distinct from the integrin receptors for Lm, which include >1A1 and >6A1 (44) . Thus, the presence of TnC may stimulate microglia to express more TnC receptors, from which downstream signaling may result in functionally different outcomes. Microglia express >v and A1 integrins (45) , and although altered integrin expression on microglia may result from psychosine levels in GLD, other cytokines that are also produced in the CNS during GLD may also contribute to microglial activation (43) . In particular, the cytokines transforming growth factor A, TNF, and interleukin-1A, which are known to be elevated in GLD, have also been reported to induce a diversity of > and A integrin expression on microglia (45) . Moreover, the ECM composition itself can induce changes in microglial integrin expression (45) . Based on our findings in this report, further analysis of integrin expression on microglia and their role in mediating the cellular responses to psychosine in the presence of TnC would be expected to provide additional mechanistic insights into the pathologic activation of microglia in GLD.
It is important to point out that TnC is a putative substrate of MMP-3. The concomitant increase of MMP-3 expression in GLD with the significant modulation of microglial response to psychosine on TnC suggests several potentially important associations between TnC and MMP-3. For example, we have determined that TnC dramatically increased mmp-3 mRNA expression in glia (Fig. 2) and previous work by others has investigated enzymatically targeted TnC and several cleaved TnC products (46, 47) . Although the binding capacities or the signaling potentials of cleaved TnC fragments are not known, it is possible that fragmented TnC may bind to integrins differently from full-length TnC and modulate signaling that results in microglial phenotypic changes. Future studies would be required to elucidate the involvement of integrins and possible TnC proteolysis on cellular phenotype changes induced by TnC on microglia in response to psychosine.
Globoid cells in situ frequently contain tubular inclusions and myelin debris (35, 48) , but their function in GLD is unclear. Our in vitro analyses and modeling indicate that the local presence of TnC dramatically limits any potential beneficial function of globoid cells in GLD. Consistent with our in vitro data, we also identified M1 polarized microglia and globoid cells within brain tissues from human GLD specimens. We report that globoid cells behave differently depending on their local extracellular environment. Thus, GLD pathophysiology is likely a much more dynamic process than previously recognized. Indeed, cord stem cell and bone marrow transplantation, while yielding encouraging but limited effectiveness, may be influenced by altered ECM constituents in GLD. In particular, TnC may be a limiting factor for current therapeutic strategies and, because it has diverse functions on cellular growth, maturation, and repulsion of cells (37) , it may also impact the activation phenotype of transplanted cells. At MS lesions, increased TnC may have a beneficial role to promote cell growth, but it is also possible that prolonged TnC elevations may also prevent the migration of progenitor cells necessary for mediating repair (49, 50) . Tenascin-C deposits in twitcher brain exhibited a unique pattern of plaque-like clustering in multiple brain regions, and some TnC-positive clusters were positive for thioflavin-S, an amyloid marker (51) . In addition, neuronal source would be consistent with the colocalization of TnC foci that also stained for thioflavin-S in the twitcher mouse brain. These findings are also in agreement with our recent report on the development of intraneuronal inclusions containing >-synuclein in GLD (51) . Further analysis of GLD pathology is needed to improve our understanding of the cellular source of TnC in GLD and to characterize the composition of extracellular plaques identified by TnC staining patterns in this disease.
In summary, we have defined a major role for globoid cells in the pathophysiology of GLD.
The importance of the ECM microenvironment in GLD was also highlighted by the enhanced transformation of microglia in response to psychosine when in the presence of TnC. Further detailed analyses on the temporal and spatial functions of TnC expression in the CNS would be required to elucidate the stage and full significance of TnC to GLD pathology. Future consideration of whether this process could be adopted to modify pathogenic microglial functions and how this understanding may be therapeutically applied in GLD may be warranted.
